Rei Maeda

Rei Maeda is currently an advisor for Safety Medical and Epidemiology/Database Research group in Eli Lilly Japan. Over ten years, he is cross-functionally working for therapeutic risk management planning area inside and outside a company. He is also a member for AMED Investigation project regarding improving RMP for seven years, His contribution to DIA Japan includes Program Committee Member, Session Chair and Facilitator of chatting session at DIA Annual meeting 2012-2017. And includs Program Chair of 1st -4th DIA Risk management workshop and 1st DIA Lifecycle management workshop 2018 and Contents Committee member (Safety/PV) 2016/1-2018/11.